Showing results (1-10 of 2) with videos related to
Sort By:
Pageof 1
Expert Opinion on Biological Therapy|May 20, 2024
Next-generation CD40 agonists for cancer immunotherapyHampus Andersson, Barnabas Nyesiga, Tova Hermodsson, et al.Cancer Immunology Research|September 10, 2025
ATOR-4066, a Bispecific Antibody Targeting CD40 and CEACAM5, Induces Strong Myeloid and T Cell-Dependent Tumor Immunity and Synergizes with PD-1 BlockadeHampus Andersson, Ida Uddbäck, Tova Hermodsson, et al.Pageof 1